Diagnostic value of radionuclide in bone metastasis after breast cancer surgery: A protocol of systematic review

0Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Background:The objective of this study is to evaluate the accuracy of radionuclide in diagnosis of bone metastasis (BM) after breast cancer surgery (BCS).Methods:The electronic databases (Cochrane Library, MEDLINE, EMBASE, Web of Science, CBM, and CNKI) will be systematically and comprehensively searched until June 1, 2020 for eligible studies that reported the diagnosis of radionuclide in BM after BCS. In addition, we will also identify grey literatures, such as conference abstracts, and reference lists of included studies. All process of study identification, data extraction, and study methodological quality evaluation will be performed by 2 independent authors. All divergences will be settled by a third author through discussion. All data analysis will be carried out by RevMan 5.3 software (London, UK).Results:This study will scrutinize the most recent evidence of radionuclide in detection of BM after BCS.Conclusion:This study may provide evidence of accuracy of radionuclide in diagnosis of BM following BCS.

Cite

CITATION STYLE

APA

Lian, Q. X., Zhao, W., Li, G., Jin, L. J., & Nie, H. J. (2020, August 14). Diagnostic value of radionuclide in bone metastasis after breast cancer surgery: A protocol of systematic review. Medicine (United States). Lippincott Williams and Wilkins. https://doi.org/10.1097/MD.0000000000021585

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free